New patent for Fresenius Kabi drug DILAUDID

   May 25, 2023    Comments Off on New patent for Fresenius Kabi drug DILAUDID    Posted in: Patent Added

Annual Drug Patent Expirations for DILAUDID Dilaudid is a drug marketed by Fresenius Kabi Usa and Rhodes Pharms and is included in three NDAs. It is available from four suppliers.…

The post New patent for Fresenius Kabi drug DILAUDID appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog